COMMUNITY-LED ACTION IS THE CRUCIAL COUNTERMEASURE
In this report, ITPC presents the evidence of the sizeable impact of community-led action.
Archives: Resources
Resources
-
-
Monitoring Results of State Procurement of ARV Drugs in the Russian Federation in 2022
The main purpose of this document is to support efforts to fight the HIV epidemic in Russia.
-
Pre-exposure HIV prophylaxis in Russia: market analysis for 2022
The main objective of the study is to assess the existing market of pre-exposure prophylaxis of HIV (PrEP) in Russia.
-
Community-led monitoring of COVID-19’s effects on service delivery and lived experiences of people living with HIV and TB in China, Guatemala, India, Nepal and Sierra Leone
With funding from UNAIDS, the ITPC adapted its Community Treatment Observatory (CTO) model to rapidly implement short-term Community-Led Monitoring and Advocacy (CLM &A) during the COVID-19 pandemic.
-
NOT PITY, PARTNERSHIP: THE RISE OF COMMUNITY LEADERSHIP | ITPC Annual Review 2022
Our 20 Year Anniversary Special Edition not only reflects where have come from, but who we are; it showcases our 2022 work and shares our vision for the work ahead.
-
Community-Led Monitoring For Increased Community Engagement in DSD Decision-Making and Programming
In collaboration with the ITPC, the Community Advocacy Network (CAN) members developed a Community Engagement Framework and a monitoring tool to promote community engagement across various levels (policy, programmatic, community) and areas (design, implementation, M&E).
-
Access to COVID-19 Vaccines From Oxford/AstraZeneca, Johnson & Johnson, Moderna & Pfizer/BioNTech in 17 Middle-Income Countries
The report assesses and provides detailed information on the availability and affordability of COVID-19 vaccines from Oxford/AstraZeneca, Johnson and Johnson (J & J), Moderna, and Pfizer/BioNTech, covering 17 MICs where our Make Medicines Affordable (MMA) campaign partners work. The information they gathered covers vaccine supply, delivery, donations, pricing and technology transfer during the period between 1 January 2021 and 19 January 2022.
-
Results Matter: Community-Led Monitoring of Routine Viral Load & CD4 Cell Count Testing in Sierra Leone & Kenya
This pilot of community-led monitoring (CLM) of routine viral load testing (RVLT) and CD4 cell count testing, carried out in Kenya and Sierra Leone, confirms that the presence of guidelines and policies cannot be used as a proxy for coverage and access to these tests.
-
‘Citizen Science’ Quantitative Community-Led Monitoring Results (IAS 2023)
ITPC presented recent quantitative findings from the Citizen Science community-led monitoring (CLM) project at the 12th International AIDS Society Conference on HIV Science (IAS 2023), 23-26 July 2023, Brisbane, Australia.
-
Citizen Science Life Maps 2022 Report
Citizen Science Life Maps is a three-year qualitative, longitudinal research project conducted in South Africa and Malawi under the leadership of ITPC. This report documents the 2022 results of the project.
-
Bouncing Back
This report shares data and advocacy outcomes from 2022. It tells an optimistic story of recovery and resilience, highlighting how community-led initiatives can help restore health services in the aftershock of a crisis like COVID-19.
-
A community guide for introducing Decision-makers to using CLM Data
The purpose of this guide is to educate, orient, and sensitize different types of decision-makers about how to value and utilize Community-led Monitoring (CLM) data.
